Dacomitinib 45mg EGFR Inhibitor $80

Dacomitinib’s job is to stop the EGFR kinase, which helps treat a type of lung cancer called NSCLC. It’s really good at targeting those with a specific mutation, like EGFR exon 19 deletion or L858R in exon 21. It stops the EGFR signaling in its tracks.

You can get Dacomitinib in 15 mg, 30 mg, or 45 mg strengths, and they come in a film-coated tablet form. The usual dose they suggest is 45 mg, taken just once a day with food. You’ll find the stuff in bottles, with each one holding 30 tablets.